367 related articles for article (PubMed ID: 20716963)
1. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
[TBL] [Abstract][Full Text] [Related]
2. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.
Wu H; Tao J; Chen PJ; Shahab A; Ge W; Hart RP; Ruan X; Ruan Y; Sun YE
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18161-6. PubMed ID: 20921386
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model.
Petazzi P; Sandoval J; Szczesna K; Jorge OC; Roa L; Sayols S; Gomez A; Huertas D; Esteller M
RNA Biol; 2013 Jul; 10(7):1197-203. PubMed ID: 23611944
[TBL] [Abstract][Full Text] [Related]
6. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
[TBL] [Abstract][Full Text] [Related]
7. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
[TBL] [Abstract][Full Text] [Related]
8. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
9. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 loss-of-function dysregulates microRNAs regionally and disrupts excitatory/inhibitory synaptic transmission balance.
Horvath PM; Piazza MK; Kavalali ET; Monteggia LM
Hippocampus; 2022 Aug; 32(8):610-623. PubMed ID: 35851733
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.
Koelsch KA; Webb R; Jeffries M; Dozmorov MG; Frank MB; Guthridge JM; James JA; Wren JD; Sawalha AH
J Autoimmun; 2013 Mar; 41():168-74. PubMed ID: 23428850
[TBL] [Abstract][Full Text] [Related]
12. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
14. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.
Roux JC; Zala D; Panayotis N; Borges-Correia A; Saudou F; Villard L
Neurobiol Dis; 2012 Feb; 45(2):786-95. PubMed ID: 22127389
[TBL] [Abstract][Full Text] [Related]
15. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
[TBL] [Abstract][Full Text] [Related]
16. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Samaco RC; Hogart A; LaSalle JM
Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
[TBL] [Abstract][Full Text] [Related]
18. Histone H3 and H4 modification profiles in a Rett syndrome mouse model.
Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M
Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622
[TBL] [Abstract][Full Text] [Related]
19. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.
Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A
Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
